Apotheca Biosciences Inc. appointed P.C. Sundareswaran as chairman and CEO, effective Jan. 1, 2019.

The Saint Petersburg, Fla.-based company said Sam Talari had resigned as CEO and director on Dec. 4. Apotheca said Talari's decision was based on personal matters and not related to any disagreement with the company.

The company's Chief Technology Officer John Verghese will act as CEO until Sundareswaran assumes the role.

In addition, Apotheca COO Deidre Fernandes was elected as a board member, effective Dec. 4.

Apotheca develops nutraceuticals, formulations, and delivery technologies for the healthcare and consumer care industry.